http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2010023382-A1

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_429dc9f12a4d7efe53b79d29ade35af5
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_284e84a82d7ce889b53b45c6c1391f3a
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_68a0d9b79545cb13674ee0f20a0e56cc
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_47d5904cd8b48123356c2ae179971afa
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_859a1c14b9c49d1234e9fa4deba9681e
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_fd886fa4463a2bdb3d8c0ce6cde00a0c
classificationCPCAdditional http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K2317-56
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K2317-73
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2039-505
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K16-2863
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K16-28
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K39-395
filingDate 2009-08-26-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_9ca12f12ecf55662ac75953e70884036
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_24c167fbd551469cd3a281235ae67836
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_c891a0ddefc2a6c3b40cdd5fe40aa2b0
publicationDate 2010-03-04-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber WO-2010023382-A1
titleOfInvention Induction of p53 expression by neutralization of neuropilin-2 for the treatment of cancers
abstract The present invention relates to the use of anti-human neuropilin-2 antibodies, or of ligands of human neuropilin-2 derived from these antibodies, for obtaining a medicament for increasing p53 expression and for inducing tumour cell apoptosis in the context of an anticancer treatment.
priorityDate 2008-08-27-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2006251650-A1
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID54226752
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID136010750
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID216239
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6456016
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226395685
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226411706
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID129019136
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226409524
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226435832
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID1134
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5789
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5329102
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226409525
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID128611606
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID64966
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226435833
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID247499656
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID3086686
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6249
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID439530
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6323481
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID19772918
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226399351
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226399464
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID136301090
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226399350

Total number of triples: 50.